Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 4Rectal Neoplasms 1Neoplastic Cells, Circulating 1Neoplasms 1Hypoxia 1Gynecologic Cancer 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Oxaliplatin 47Capecitabine 46Fluorouracil 40Leucovorin 30Radiotherapy 25Irinotecan 20Chemoradiotherapy 14Bevacizumab 14Cetuximab 12Neoadjuvant Therapy 11Folfox protocol 11Chemotherapy, Adjuvant 11XELOX 10Laparoscopy 10Drug Therapy 9Surgical Procedures, Operative 6Robotic Surgical Procedures 5Radiation 5Mastectomy, Segmental 5Surveys and Questionnaires 4Radiotherapy, Intensity-Modulated 4Panitumumab 4Gemcitabine 4FOLFOXIRI protocol 4durvalumab 3Simvastatin 3Magnetic Resonance Spectroscopy 3Indocyanine Green 3tislelizumab 2regorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Rectal Neoplasms × Diagnostic Imaging × Clear all
NCT02640586 2023-06-22

Predicting Neoadjuvant Therapy Response of Rectal Cancer With MRI

Peking University Cancer Hospital & Institute

Phase NA Unknown
1,614 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡